Qing XIe

Quick facts

Phase 2 pipeline

• Direct-acting antiviral agents · Infectious Disease
  Direct-acting antiviral agents target viral replication by inhibiting viral enzymes or proteins.

Phase 1 pipeline

• NAs monotherapy group
• Peginterferon α-2b based treatment group

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Qing XIe portfolio CI brief
• Qing XIe pipeline updates RSS

Related

• Sector hub: All tracked pharma companies